Consumer Brands · NYSE: MO
Altria earnings: results, call transcripts & KPI history
2 quarters · fiscal year ends December · next results expected around 28 Jan 2027
Latest: Q3 2026
Altria expanded on! PLUS nationally with 12-milligram strength and new flavors while suing the FDA over slow authorization of new nicotine products.
Altria's pouch brand on! grew shipments 13.3% to 47.8 million cans as nicotine pouches passed 60% of the oral category. Helix rolled out on! PLUS 12-milligram nationally and added Blueberry Mint and Mango Pineapple, with Watermelon Mint next. In cigarettes, Marlboro Cowboy Cut gave price-sensitive smokers a premium option, lifting Marlboro's share of premium to 60.0%, while Basic gained share in discount.
Quarters
KPI history
Fourth quarter worked out from the annual figure.
Data
| Q4 2024 | $6.0B * |
| Q1 2025 | $5.3B |
| Q2 2025 | $6.1B |
| Q3 2025 | $6.1B |
| Q4 2025 | $5.8B * |
| Q1 2026 | $5.4B |
| Q2 2026 | $6.1B |
| Q3 2026 | $6.1B |
Data
| Q1 2025 | $0.63 |
| Q2 2025 | $1.41 |
| Q3 2025 | $1.41 |
| Q1 2026 | $1.30 |
| Q2 2026 | $1.37 |
| Q3 2026 | $1.51 |
Fourth-quarter EPS appears once the press release is read; filings report it only for the full year.
Data
| Q4 2024 | 48.2% |
| Q1 2025 | 34.0% |
| Q2 2025 | 52.9% |
| Q3 2025 | 53.2% |
| Q4 2025 | 28.2% |
| Q1 2026 | 54.5% |
| Q2 2026 | 51.3% |
| Q3 2026 | 54.0% |
Data
| Q4 2024 | $3.3B |
| Q1 2025 | $2.7B |
| Q2 2025 | $173.0M |
| Q3 2025 | $3.0B |
| Q4 2025 | $3.2B |
| Q1 2026 | $2.2B |
| Q2 2026 | $662.0M |
| Q3 2026 | $3.0B |
Operating cash flow minus capital expenditure, from cash flow statements.
| Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.0Bd | $5.3B | $6.1B | $6.1B | $5.8Bd | $5.4B | $6.1B | $6.1B |
| Gross margin | 60.3% | 61.8% | 63.1% | 62.8% | 62.1% | 64.6% | 62.5% | 64.3% |
| Operating income | $2.9Bd | $1.8B | $3.2B | $3.2B | $1.7Bd | $3.0B | $3.1B | $3.3B |
| Operating margin | 48.2% | 34.0% | 52.9% | 53.2% | 28.2% | 54.5% | 51.3% | 54.0% |
| Net income | $3.0Bd | $1.1B | $2.4B | $2.4B | $1.1Bd | $2.2B | $2.3B | $2.5B |
| Diluted EPS | — | $0.63 | $1.41 | $1.41 | — | $1.30 | $1.37 | $1.51 |
| Operating cash flow | $3.3Bd | $2.7B | $205.0Md | $3.1Bd | $3.3Bd | $2.3B | $719.0Md | $3.1Bd |
| Capital expenditure | $47.0Md | $38.0M | $32.0Md | $54.0Md | $92.0Md | $93.0M | $57.0Md | $109.0Md |
| Free cash flow | $3.3B | $2.7B | $173.0M | $3.0B | $3.2B | $2.2B | $662.0M | $3.0B |
From XBRL data in 10-Q and 10-K filings. d derived: a fourth quarter is the full year minus the first nine months, and cash flows are year-to-date figures differenced.
10-K and 10-Q filings
- 29 Oct 202610-Q for the period ended 30 Sep 2026SEC ↗
- 30 Jul 202610-Q for the period ended 30 Jun 2026SEC ↗
- 30 Apr 202610-Q for the period ended 31 Mar 2026SEC ↗
- 25 Feb 202610-K for the period ended 31 Dec 2025SEC ↗
- 30 Oct 202510-Q for the period ended 30 Sep 2025SEC ↗
- 30 Jul 202510-Q for the period ended 30 Jun 2025SEC ↗
- 29 Apr 202510-Q for the period ended 31 Mar 2025SEC ↗
- 26 Feb 202510-K for the period ended 31 Dec 2024SEC ↗